The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
02/13/2013
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
CDC-RFA-PS13-1306
Opportunity Category:
Discretionary
Posted Date:
Feb 13, 2013
Creation Date:
Feb 13, 2013
Original Closing Date for Applications:
Apr 30, 2013
Letter of Intent Deadline Date: March 15, 2013
If you chose to submit a LOI, it must be received via express mail, delivery service, fax or e-mail to:
Mark Stenger, MA
SSuN Co-Project Officer
Department of Health and Human Services
Centers for Disease Control and Prevention
Division of STD Prevention
1600 Clifton Road NE, Mailstop E-02
Atlanta, GA 30333
Telephone: 404-639-8260
Email: zpl4@cdc.gov
Application Deadline Date: April 30, 2013, 11:59 p.m. U.S. Eastern Standard Time, on www.grants.gov
Current Closing Date for Applications:
Apr 30, 2013
Letter of Intent Deadline Date: March 15, 2013
If you chose to submit a LOI, it must be received via express mail, delivery service, fax or e-mail to:
Mark Stenger, MA
SSuN Co-Project Officer
Department of Health and Human Services
Centers for Disease Control and Prevention
Division of STD Prevention
1600 Clifton Road NE, Mailstop E-02
Atlanta, GA 30333
Telephone: 404-639-8260
Email: zpl4@cdc.gov
Application Deadline Date: April 30, 2013, 11:59 p.m. U.S. Eastern Standard Time, on www.grants.gov
Archive Date:
May 30, 2013
Funding Instrument Type:
Cooperative Agreement
Category of Funding Activity:
Health
Category Explanation:
Expected Number of Awards:
18
Estimated Total Program Funding:
$30,000,000
Award Ceiling:
$1,100,000
Award Floor:
$375,000
CFDA Number(s):
93.977
--
Preventive Health Services_Sexually Transmitted Diseases Control Grants
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Eligible Applicants:
Limited competition. Part A and Part B: Eligible applicants that can apply for this funding opportunity are listed below:
•State and local governments or their Bona Fide Agents that are current recipients of funding for Comprehensive STD Prevention Systems Cooperative Agreements (this includes the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, Virgin Islands, Baltimore City, City of Chicago, New York City, Philadelphia, Los Angeles, and San Francisco)
•American Indian/Alaska Native tribal governments (federally recognized or state-recognized)
Participation in the STD surveillance network requires the funded entity to have the legal and programmatic capacity to collect and monitor personally identified public health surveillance data within their jurisdiction, as well as the programmatic capacity to respond to emerging trends in disease and risk factors.
A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with “Other Attachment Forms” when submitting via www.grants.gov.
Applicants may apply for Part A alone, Part B alone or may apply for Part A and Part B.
Agency Name
Centers for Disease Control and Prevention
Description
The activities described in this FOA are designed to generate new data that will address longstanding gaps and issues in national STD surveillance. Additionally, this FOA will fund innovative and robust collaborations with private and public healthcare partners and model technological approaches to integrated STD surveillance that make sustainable use of advances in electronic health data. Awardees successfully conducting both Part A and Part B activities described in this FOA will significantly enhance core capacity for STD surveillance in the United States and better meet CDC’s overall surveillance mandate by serving as ‘Centers of Excellence for STD Surveillance’.
The purpose of Part A activities is to sustainably enhance and improve STD surveillance data available to inform a more comprehensive understanding of trends and determinants of STDs of interest, monitor public health program impact and provide a more robust evidence base for directing public health action. STDs of interest are broadly defined as the nationally notifiable STDs including chlamydial infection, gonorrhea, syphilis, congenital syphilis and chancroid. Additionally, non-reportable bacterial and viral STDs are also of interest where network resources allow.
The purpose of Part B is to provide support to build sustainable technical capacity in selected project areas to pilot and evaluate projects that make full and meaningful use of innovations in health information technology to collect data to enhance the quality of STD surveillance and services evaluation activities.
